MedTrace Logo

Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE

NCT06000865 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-07-28

No results posted yet for this study

Summary

Falls are one of the most serious public health concerns for seniors, with significant medical and economic consequences. This concern is even higher in patients with peripheral field loss due to glaucoma because of the patients' compromised visual input. The investigators' project proposes an innovative, entertaining, easily accessible and enjoyable intervention for improving mobility and postural control function in glaucoma patients with peripheral vision loss, who are more prone to falls and suffer from fear of falling. The new intervention examined in this project can be implemented in current vision and balance rehabilitation programs, and may benefit patients with different types of visual impairment to minimize their risk of falls and improve their quality of life.

Conditions

Interventions

BEHAVIORAL

Action video game training

20 sessions of AVG over 10 weeks (45 minutes per session, 2 sessions per week)

BEHAVIORAL

Conventional physical training

20 sessions of physical training over 10 weeks (45 minutes per session, 2 sessions per week)

Sponsors & Collaborators

  • University of Waterloo

    collaborator OTHER

  • The University of Hong Kong

    collaborator OTHER

  • University of Leicester

    collaborator OTHER

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Allen Cheong, PhD · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-09
Primary Completion
2025-07-30
Completion
2025-12-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06000865 on ClinicalTrials.gov